Global Severe Hypoglycemia Treatment Market Research Report 2024

Report ID: 1549402 | Published Date: Jan 2025 | No. of Page: 83 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Severe Hypoglycemia Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Subcutaneous Treatment
        1.2.3 Parenteral Treatment
        1.2.4 Intravenous Treatment
        1.2.5 Oral Treatment
        1.2.6 Intranasal Treatment
    1.3 Market by Application
        1.3.1 Global Severe Hypoglycemia Treatment Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Online Pharmacies
        1.3.4 Independent Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Severe Hypoglycemia Treatment Market Perspective (2017-2028)
    2.2 Severe Hypoglycemia Treatment Growth Trends by Region
        2.2.1 Severe Hypoglycemia Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Severe Hypoglycemia Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Severe Hypoglycemia Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Severe Hypoglycemia Treatment Market Dynamics
        2.3.1 Severe Hypoglycemia Treatment Industry Trends
        2.3.2 Severe Hypoglycemia Treatment Market Drivers
        2.3.3 Severe Hypoglycemia Treatment Market Challenges
        2.3.4 Severe Hypoglycemia Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Severe Hypoglycemia Treatment Players by Revenue
        3.1.1 Global Top Severe Hypoglycemia Treatment Players by Revenue (2017-2022)
        3.1.2 Global Severe Hypoglycemia Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Severe Hypoglycemia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Severe Hypoglycemia Treatment Revenue
    3.4 Global Severe Hypoglycemia Treatment Market Concentration Ratio
        3.4.1 Global Severe Hypoglycemia Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Severe Hypoglycemia Treatment Revenue in 2021
    3.5 Severe Hypoglycemia Treatment Key Players Head office and Area Served
    3.6 Key Players Severe Hypoglycemia Treatment Product Solution and Service
    3.7 Date of Enter into Severe Hypoglycemia Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Severe Hypoglycemia Treatment Breakdown Data by Type
    4.1 Global Severe Hypoglycemia Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Severe Hypoglycemia Treatment Forecasted Market Size by Type (2023-2028)
5 Severe Hypoglycemia Treatment Breakdown Data by Application
    5.1 Global Severe Hypoglycemia Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Severe Hypoglycemia Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Severe Hypoglycemia Treatment Market Size (2017-2028)
    6.2 North America Severe Hypoglycemia Treatment Market Size by Country (2017-2022)
    6.3 North America Severe Hypoglycemia Treatment Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Severe Hypoglycemia Treatment Market Size (2017-2028)
    7.2 Europe Severe Hypoglycemia Treatment Market Size by Country (2017-2022)
    7.3 Europe Severe Hypoglycemia Treatment Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Severe Hypoglycemia Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Severe Hypoglycemia Treatment Market Size by Country (2017-2022)
    8.3 Asia-Pacific Severe Hypoglycemia Treatment Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Severe Hypoglycemia Treatment Market Size (2017-2028)
    9.2 Latin America Severe Hypoglycemia Treatment Market Size by Country (2017-2022)
    9.3 Latin America Severe Hypoglycemia Treatment Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Severe Hypoglycemia Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Severe Hypoglycemia Treatment Market Size by Country (2017-2022)
    10.3 Middle East & Africa Severe Hypoglycemia Treatment Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Xeris Pharmaceuticals
        11.1.1 Xeris Pharmaceuticals Company Detail
        11.1.2 Xeris Pharmaceuticals Business Overview
        11.1.3 Xeris Pharmaceuticals Severe Hypoglycemia Treatment Introduction
        11.1.4 Xeris Pharmaceuticals Revenue in Severe Hypoglycemia Treatment Business (2017-2022)
        11.1.5 Xeris Pharmaceuticals Recent Development
    11.2 Zealand Pharma
        11.2.1 Zealand Pharma Company Detail
        11.2.2 Zealand Pharma Business Overview
        11.2.3 Zealand Pharma Severe Hypoglycemia Treatment Introduction
        11.2.4 Zealand Pharma Revenue in Severe Hypoglycemia Treatment Business (2017-2022)
        11.2.5 Zealand Pharma Recent Development
    11.3 Torrent Labs
        11.3.1 Torrent Labs Company Detail
        11.3.2 Torrent Labs Business Overview
        11.3.3 Torrent Labs Severe Hypoglycemia Treatment Introduction
        11.3.4 Torrent Labs Revenue in Severe Hypoglycemia Treatment Business (2017-2022)
        11.3.5 Torrent Labs Recent Development
    11.4 Taj Pharmaceuticals
        11.4.1 Taj Pharmaceuticals Company Detail
        11.4.2 Taj Pharmaceuticals Business Overview
        11.4.3 Taj Pharmaceuticals Severe Hypoglycemia Treatment Introduction
        11.4.4 Taj Pharmaceuticals Revenue in Severe Hypoglycemia Treatment Business (2017-2022)
        11.4.5 Taj Pharmaceuticals Recent Development
    11.5 Novo Nordisk
        11.5.1 Novo Nordisk Company Detail
        11.5.2 Novo Nordisk Business Overview
        11.5.3 Novo Nordisk Severe Hypoglycemia Treatment Introduction
        11.5.4 Novo Nordisk Revenue in Severe Hypoglycemia Treatment Business (2017-2022)
        11.5.5 Novo Nordisk Recent Development
    11.6 Amphastar Pharmaceuticals
        11.6.1 Amphastar Pharmaceuticals Company Detail
        11.6.2 Amphastar Pharmaceuticals Business Overview
        11.6.3 Amphastar Pharmaceuticals Severe Hypoglycemia Treatment Introduction
        11.6.4 Amphastar Pharmaceuticals Revenue in Severe Hypoglycemia Treatment Business (2017-2022)
        11.6.5 Amphastar Pharmaceuticals Recent Development
    11.7 Fresenius Kabi
        11.7.1 Fresenius Kabi Company Detail
        11.7.2 Fresenius Kabi Business Overview
        11.7.3 Fresenius Kabi Severe Hypoglycemia Treatment Introduction
        11.7.4 Fresenius Kabi Revenue in Severe Hypoglycemia Treatment Business (2017-2022)
        11.7.5 Fresenius Kabi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Severe Hypoglycemia Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Subcutaneous Treatment
    Table 3. Key Players of Parenteral Treatment
    Table 4. Key Players of Intravenous Treatment
    Table 5. Key Players of Oral Treatment
    Table 6. Key Players of Intranasal Treatment
    Table 7. Global Severe Hypoglycemia Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Severe Hypoglycemia Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Severe Hypoglycemia Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Severe Hypoglycemia Treatment Market Share by Region (2017-2022)
    Table 11. Global Severe Hypoglycemia Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Severe Hypoglycemia Treatment Market Share by Region (2023-2028)
    Table 13. Severe Hypoglycemia Treatment Market Trends
    Table 14. Severe Hypoglycemia Treatment Market Drivers
    Table 15. Severe Hypoglycemia Treatment Market Challenges
    Table 16. Severe Hypoglycemia Treatment Market Restraints
    Table 17. Global Severe Hypoglycemia Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Severe Hypoglycemia Treatment Market Share by Players (2017-2022)
    Table 19. Global Top Severe Hypoglycemia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Severe Hypoglycemia Treatment as of 2021)
    Table 20. Ranking of Global Top Severe Hypoglycemia Treatment Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Severe Hypoglycemia Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Severe Hypoglycemia Treatment Product Solution and Service
    Table 24. Date of Enter into Severe Hypoglycemia Treatment Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Severe Hypoglycemia Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Severe Hypoglycemia Treatment Revenue Market Share by Type (2017-2022)
    Table 28. Global Severe Hypoglycemia Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Severe Hypoglycemia Treatment Revenue Market Share by Type (2023-2028)
    Table 30. Global Severe Hypoglycemia Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Severe Hypoglycemia Treatment Revenue Market Share by Application (2017-2022)
    Table 32. Global Severe Hypoglycemia Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Severe Hypoglycemia Treatment Revenue Market Share by Application (2023-2028)
    Table 34. North America Severe Hypoglycemia Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America Severe Hypoglycemia Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe Severe Hypoglycemia Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe Severe Hypoglycemia Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific Severe Hypoglycemia Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific Severe Hypoglycemia Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America Severe Hypoglycemia Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America Severe Hypoglycemia Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa Severe Hypoglycemia Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa Severe Hypoglycemia Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Xeris Pharmaceuticals Company Detail
    Table 45. Xeris Pharmaceuticals Business Overview
    Table 46. Xeris Pharmaceuticals Severe Hypoglycemia Treatment Product
    Table 47. Xeris Pharmaceuticals Revenue in Severe Hypoglycemia Treatment Business (2017-2022) & (US$ Million)
    Table 48. Xeris Pharmaceuticals Recent Development
    Table 49. Zealand Pharma Company Detail
    Table 50. Zealand Pharma Business Overview
    Table 51. Zealand Pharma Severe Hypoglycemia Treatment Product
    Table 52. Zealand Pharma Revenue in Severe Hypoglycemia Treatment Business (2017-2022) & (US$ Million)
    Table 53. Zealand Pharma Recent Development
    Table 54. Torrent Labs Company Detail
    Table 55. Torrent Labs Business Overview
    Table 56. Torrent Labs Severe Hypoglycemia Treatment Product
    Table 57. Torrent Labs Revenue in Severe Hypoglycemia Treatment Business (2017-2022) & (US$ Million)
    Table 58. Torrent Labs Recent Development
    Table 59. Taj Pharmaceuticals Company Detail
    Table 60. Taj Pharmaceuticals Business Overview
    Table 61. Taj Pharmaceuticals Severe Hypoglycemia Treatment Product
    Table 62. Taj Pharmaceuticals Revenue in Severe Hypoglycemia Treatment Business (2017-2022) & (US$ Million)
    Table 63. Taj Pharmaceuticals Recent Development
    Table 64. Novo Nordisk Company Detail
    Table 65. Novo Nordisk Business Overview
    Table 66. Novo Nordisk Severe Hypoglycemia Treatment Product
    Table 67. Novo Nordisk Revenue in Severe Hypoglycemia Treatment Business (2017-2022) & (US$ Million)
    Table 68. Novo Nordisk Recent Development
    Table 69. Amphastar Pharmaceuticals Company Detail
    Table 70. Amphastar Pharmaceuticals Business Overview
    Table 71. Amphastar Pharmaceuticals Severe Hypoglycemia Treatment Product
    Table 72. Amphastar Pharmaceuticals Revenue in Severe Hypoglycemia Treatment Business (2017-2022) & (US$ Million)
    Table 73. Amphastar Pharmaceuticals Recent Development
    Table 74. Fresenius Kabi Company Detail
    Table 75. Fresenius Kabi Business Overview
    Table 76. Fresenius Kabi Severe Hypoglycemia Treatment Product
    Table 77. Fresenius Kabi Revenue in Severe Hypoglycemia Treatment Business (2017-2022) & (US$ Million)
    Table 78. Fresenius Kabi Recent Development
    Table 79. Research Programs/Design for This Report
    Table 80. Key Data Information from Secondary Sources
    Table 81. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Severe Hypoglycemia Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Subcutaneous Treatment Features
    Figure 3. Parenteral Treatment Features
    Figure 4. Intravenous Treatment Features
    Figure 5. Oral Treatment Features
    Figure 6. Intranasal Treatment Features
    Figure 7. Global Severe Hypoglycemia Treatment Market Share by Application in 2021 & 2028
    Figure 8. Hospital Pharmacies Case Studies
    Figure 9. Online Pharmacies Case Studies
    Figure 10. Independent Pharmacies Case Studies
    Figure 11. Severe Hypoglycemia Treatment Report Years Considered
    Figure 12. Global Severe Hypoglycemia Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Severe Hypoglycemia Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Severe Hypoglycemia Treatment Market Share by Region: 2021 VS 2028
    Figure 15. Global Severe Hypoglycemia Treatment Market Share by Players in 2021
    Figure 16. Global Top Severe Hypoglycemia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Severe Hypoglycemia Treatment as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Severe Hypoglycemia Treatment Revenue in 2021
    Figure 18. North America Severe Hypoglycemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. North America Severe Hypoglycemia Treatment Market Share by Country (2017-2028)
    Figure 20. United States Severe Hypoglycemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Severe Hypoglycemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Severe Hypoglycemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Severe Hypoglycemia Treatment Market Share by Country (2017-2028)
    Figure 24. Germany Severe Hypoglycemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Severe Hypoglycemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Severe Hypoglycemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Severe Hypoglycemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Severe Hypoglycemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Severe Hypoglycemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Severe Hypoglycemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Severe Hypoglycemia Treatment Market Share by Region (2017-2028)
    Figure 32. China Severe Hypoglycemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Japan Severe Hypoglycemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. South Korea Severe Hypoglycemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Southeast Asia Severe Hypoglycemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. India Severe Hypoglycemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Australia Severe Hypoglycemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Severe Hypoglycemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Severe Hypoglycemia Treatment Market Share by Country (2017-2028)
    Figure 40. Mexico Severe Hypoglycemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Brazil Severe Hypoglycemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Severe Hypoglycemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Severe Hypoglycemia Treatment Market Share by Country (2017-2028)
    Figure 44. Turkey Severe Hypoglycemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Saudi Arabia Severe Hypoglycemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Xeris Pharmaceuticals Revenue Growth Rate in Severe Hypoglycemia Treatment Business (2017-2022)
    Figure 47. Zealand Pharma Revenue Growth Rate in Severe Hypoglycemia Treatment Business (2017-2022)
    Figure 48. Torrent Labs Revenue Growth Rate in Severe Hypoglycemia Treatment Business (2017-2022)
    Figure 49. Taj Pharmaceuticals Revenue Growth Rate in Severe Hypoglycemia Treatment Business (2017-2022)
    Figure 50. Novo Nordisk Revenue Growth Rate in Severe Hypoglycemia Treatment Business (2017-2022)
    Figure 51. Amphastar Pharmaceuticals Revenue Growth Rate in Severe Hypoglycemia Treatment Business (2017-2022)
    Figure 52. Fresenius Kabi Revenue Growth Rate in Severe Hypoglycemia Treatment Business (2017-2022)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Xeris Pharmaceuticals
Zealand Pharma
Torrent Labs
Taj Pharmaceuticals
Novo Nordisk
Amphastar Pharmaceuticals
Fresenius Kabi
Frequently Asked Questions
Severe Hypoglycemia Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Severe Hypoglycemia Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Severe Hypoglycemia Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Pimple Patch

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Fried Snacks

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Hangover Product

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More